Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy
Background: Patients with β-thalassemia major remain at risk for endothelial dysfunction and cardiac injury due to iron overload, oxidative stress, and chronic inflammation, even with iron-chelation therapy. Assessing vascular and cardiac serum biomarkers provides a practical tool to understand dise...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2026-02-01
|
| Edice: | Therapeutic Advances in Hematology |
| On-line přístup: | https://doi.org/10.1177/20406207261417140 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|